APO Research
Talk to an analyst

APO RESEARCH · REPORT

Verapamil

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Verapamil Market Analysis and Forecast 2026-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchVerapamil Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Verapamil Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Verapamil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Verapamil Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Verapamil Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Verapamil market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Verapamil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Verapamil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Verapamil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Verapamil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Verapamil include REPLEK FARM, YUNGSHIN PHARM IND. CO. LTD, The Central Pharmaceutical CO.,Ltd.Tianjin, Mylan and Abbott Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Verapamil, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Verapamil, also provides the sales of main regions and countries. Of the upcoming market potential for Verapamil, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Verapamil sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Verapamil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Verapamil sales, projected growth trends, production technology, application and end-user industry.

Verapamil Segment by Company

REPLEK FARM

YUNGSHIN PHARM IND. CO. LTD

The Central Pharmaceutical CO.,Ltd.Tianjin

Mylan

Abbott Laboratories

Verapamil Segment by Type

Capsules

Tablets

Injection

Others

Verapamil Segment by Application

Hospital Pharmacy

Online Sales

Retail Pharmacy

Others

Verapamil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Verapamil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Verapamil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Verapamil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Verapamil in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Verapamil manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Verapamil sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Verapamil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsules Major Manufacturers Table 3. Tablets Major Manufacturers Table 4. Injection Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Verapamil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Pharmacy Major Manufacturers Table 8. Online Sales Major Manufacturers Table 9. Retail Pharmacy Major Manufacturers Table 10. Others Major Manufacturers Table 11. Verapamil Industry Trends Table 12. Verapamil Industry Drivers Table 13. Verapamil Industry Opportunities and Challenges Table 14. Verapamil Industry Restraints Table 15. Global Verapamil Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Verapamil Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Verapamil Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Verapamil Revenue Market Share by Region (2021-2026) Table 19. Global Verapamil Revenue Market Share by Region (2027-2032) Table 20. Global Verapamil Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Verapamil Sales by Region (2021-2026) & (K Units) Table 22. Global Verapamil Sales by Region (2027-2032) & (K Units) Table 23. Global Verapamil Sales Market Share by Region (2021-2026) Table 24. Global Verapamil Sales Market Share by Region (2027-2032) Table 25. Global Verapamil Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Verapamil Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Verapamil Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Verapamil Sales Market Share by Manufacturers (2021-2026) Table 29. Global Verapamil Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Verapamil Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Verapamil Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Verapamil Manufacturers, Product Type & Application Table 33. Global Verapamil Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Verapamil by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Verapamil Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Verapamil Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Verapamil Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Verapamil Revenue Market Share by Type (2021-2026) Table 40. Global Verapamil Revenue Market Share by Type (2027-2032) Table 41. Global Verapamil Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Verapamil Sales by Type (2021-2026) & (K Units) Table 43. Global Verapamil Sales by Type (2027-2032) & (K Units) Table 44. Global Verapamil Sales Market Share by Type (2021-2026) Table 45. Global Verapamil Sales Market Share by Type (2027-2032) Table 46. Global Verapamil Price by Type (2021-2026) & (US$/Unit) Table 47. Global Verapamil Price by Type (2027-2032) & (US$/Unit) Table 48. Global Verapamil Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Verapamil Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Verapamil Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Verapamil Revenue Market Share by Application (2021-2026) Table 52. Global Verapamil Revenue Market Share by Application (2027-2032) Table 53. Global Verapamil Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Verapamil Sales by Application (2021-2026) & (K Units) Table 55. Global Verapamil Sales by Application (2027-2032) & (K Units) Table 56. Global Verapamil Sales Market Share by Application (2021-2026) Table 57. Global Verapamil Sales Market Share by Application (2027-2032) Table 58. Global Verapamil Price by Application (2021-2026) & (US$/Unit) Table 59. Global Verapamil Price by Application (2027-2032) & (US$/Unit) Table 60. REPLEK FARM Company Information Table 61. REPLEK FARM Business Overview Table 62. REPLEK FARM Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. REPLEK FARM Verapamil Product Portfolio Table 64. REPLEK FARM Recent Development Table 65. YUNGSHIN PHARM IND. CO. LTD Company Information Table 66. YUNGSHIN PHARM IND. CO. LTD Business Overview Table 67. YUNGSHIN PHARM IND. CO. LTD Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. YUNGSHIN PHARM IND. CO. LTD Verapamil Product Portfolio Table 69. YUNGSHIN PHARM IND. CO. LTD Recent Development Table 70. The Central Pharmaceutical CO.,Ltd.Tianjin Company Information Table 71. The Central Pharmaceutical CO.,Ltd.Tianjin Business Overview Table 72. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product Portfolio Table 74. The Central Pharmaceutical CO.,Ltd.Tianjin Recent Development Table 75. Mylan Company Information Table 76. Mylan Business Overview Table 77. Mylan Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Mylan Verapamil Product Portfolio Table 79. Mylan Recent Development Table 80. Abbott Laboratories Company Information Table 81. Abbott Laboratories Business Overview Table 82. Abbott Laboratories Verapamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Abbott Laboratories Verapamil Product Portfolio Table 84. Abbott Laboratories Recent Development Table 85. North America Verapamil Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Verapamil Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Verapamil Sales by Type (2021-2026) & (K Units) Table 88. North America Verapamil Sales by Type (2027-2032) & (K Units) Table 89. North America Verapamil Sales Price by Type (2021-2026) & (US$/Unit) Table 90. North America Verapamil Sales Price by Type (2027-2032) & (US$/Unit) Table 91. North America Verapamil Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Verapamil Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Verapamil Sales by Application (2021-2026) & (K Units) Table 94. North America Verapamil Sales by Application (2027-2032) & (K Units) Table 95. North America Verapamil Sales Price by Application (2021-2026) & (US$/Unit) Table 96. North America Verapamil Sales Price by Application (2027-2032) & (US$/Unit) Table 97. North America Verapamil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Verapamil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. North America Verapamil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. North America Verapamil Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 101. North America Verapamil Sales by Country (2021-2026) & (K Units) Table 102. North America Verapamil Sales by Country (2027-2032) & (K Units) Table 103. North America Verapamil Sales Price by Country (2021-2026) & (US$/Unit) Table 104. North America Verapamil Sales Price by Country (2027-2032) & (US$/Unit) Table 105. United States Verapamil Revenue (2021-2032) & (US$ Million) Table 106. Canada Verapamil Revenue (2021-2032) & (US$ Million) Table 107. Europe Verapamil Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Verapamil Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Verapamil Sales by Type (2021-2026) & (K Units) Table 110. Europe Verapamil Sales by Type (2027-2032) & (K Units) Table 111. Europe Verapamil Sales Price by Type (2021-2026) & (US$/Unit) Table 112. Europe Verapamil Sales Price by Type (2027-2032) & (US$/Unit) Table 113. Europe Verapamil Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Verapamil Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Verapamil Sales by Application (2021-2026) & (K Units) Table 116. Europe Verapamil Sales by Application (2027-2032) & (K Units) Table 117. Europe Verapamil Sales Price by Application (2021-2026) & (US$/Unit) Table 118. Europe Verapamil Sales Price by Application (2027-2032) & (US$/Unit) Table 119. Europe Verapamil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Verapamil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. Europe Verapamil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. Europe Verapamil Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. Europe Verapamil Sales by Country (2021-2026) & (K Units) Table 124. Europe Verapamil Sales by Country (2027-2032) & (K Units) Table 125. Europe Verapamil Sales Price by Country (2021-2026) & (US$/Unit) Table 126. Europe Verapamil Sales Price by Country (2027-2032) & (US$/Unit) Table 127. Germany Verapamil Revenue (2021-2032) & (US$ Million) Table 128. France Verapamil Revenue (2021-2032) & (US$ Million) Table 129. U.K. Verapamil Revenue (2021-2032) & (US$ Million) Table 130. Italy Verapamil Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Verapamil Revenue (2021-2032) & (US$ Million) Table 132. China Verapamil Revenue by Type (2021-2026) & (US$ Million) Table 133. China Verapamil Revenue by Type (2027-2032) & (US$ Million) Table 134. China Verapamil Sales by Type (2021-2026) & (K Units) Table 135. China Verapamil Sales by Type (2027-2032) & (K Units) Table 136. China Verapamil Sales Price by Type (2021-2026) & (US$/Unit) Table 137. China Verapamil Sales Price by Type (2027-2032) & (US$/Unit) Table 138. China Verapamil Revenue by Application (2021-2026) & (US$ Million) Table 139. China Verapamil Revenue by Application (2027-2032) & (US$ Million) Table 140. China Verapamil Sales by Application (2021-2026) & (K Units) Table 141. China Verapamil Sales by Application (2027-2032) & (K Units) Table 142. China Verapamil Sales Price by Application (2021-2026) & (US$/Unit) Table 143. China Verapamil Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Verapamil Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia Verapamil Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia Verapamil Sales by Type (2021-2026) & (K Units) Table 147. Asia Verapamil Sales by Type (2027-2032) & (K Units) Table 148. Asia Verapamil Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Asia Verapamil Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Asia Verapamil Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Verapamil Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Verapamil Sales by Application (2021-2026) & (K Units) Table 153. Asia Verapamil Sales by Application (2027-2032) & (K Units) Table 154. Asia Verapamil Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Asia Verapamil Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia Verapamil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Verapamil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Asia Verapamil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Asia Verapamil Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Asia Verapamil Sales by Country (2021-2026) & (K Units) Table 161. Asia Verapamil Sales by Country (2027-2032) & (K Units) Table 162. Asia Verapamil Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Asia Verapamil Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Japan Verapamil Revenue (2021-2032) & (US$ Million) Table 165. South Korea Verapamil Revenue (2021-2032) & (US$ Million) Table 166. India Verapamil Revenue (2021-2032) & (US$ Million) Table 167. Australia Verapamil Revenue (2021-2032) & (US$ Million) Table 168. China Taiwan Verapamil Revenue (2021-2032) & (US$ Million) Table 169. Southeast Asia Verapamil Revenue (2021-2032) & (US$ Million) Table 170. SAMEA Verapamil Revenue by Type (2021-2026) & (US$ Million) Table 171. SAMEA Verapamil Revenue by Type (2027-2032) & (US$ Million) Table 172. SAMEA Verapamil Sales by Type (2021-2026) & (K Units) Table 173. SAMEA Verapamil Sales by Type (2027-2032) & (K Units) Table 174. SAMEA Verapamil Sales Price by Type (2021-2026) & (US$/Unit) Table 175. SAMEA Verapamil Sales Price by Type (2027-2032) & (US$/Unit) Table 176. SAMEA Verapamil Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA Verapamil Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA Verapamil Sales by Application (2021-2026) & (K Units) Table 179. SAMEA Verapamil Sales by Application (2027-2032) & (K Units) Table 180. SAMEA Verapamil Sales Price by Application (2021-2026) & (US$/Unit) Table 181. SAMEA Verapamil Sales Price by Application (2027-2032) & (US$/Unit) Table 182. SAMEA Verapamil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. SAMEA Verapamil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. SAMEA Verapamil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. SAMEA Verapamil Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. SAMEA Verapamil Sales by Country (2021-2026) & (K Units) Table 187. SAMEA Verapamil Sales by Country (2027-2032) & (K Units) Table 188. SAMEA Verapamil Sales Price by Country (2021-2026) & (US$/Unit) Table 189. SAMEA Verapamil Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Brazil Verapamil Revenue (2021-2032) & (US$ Million) Table 191. Argentina Verapamil Revenue (2021-2032) & (US$ Million) Table 192. Chile Verapamil Revenue (2021-2032) & (US$ Million) Table 193. Colombia Verapamil Revenue (2021-2032) & (US$ Million) Table 194. Peru Verapamil Revenue (2021-2032) & (US$ Million) Table 195. Saudi Arabia Verapamil Revenue (2021-2032) & (US$ Million) Table 196. Israel Verapamil Revenue (2021-2032) & (US$ Million) Table 197. UAE Verapamil Revenue (2021-2032) & (US$ Million) Table 198. Turkey Verapamil Revenue (2021-2032) & (US$ Million) Table 199. Iran Verapamil Revenue (2021-2032) & (US$ Million) Table 200. Egypt Verapamil Revenue (2021-2032) & (US$ Million) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Verapamil Distributors List Table 204. Verapamil Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Verapamil Image Figure 2. Global Verapamil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Verapamil Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsules Image Figure 5. Tablets Image Figure 6. Injection Image Figure 7. Others Image Figure 8. Global Verapamil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Verapamil Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Pharmacy Image Figure 11. Online Sales Image Figure 12. Retail Pharmacy Image Figure 13. Others Image Figure 14. Global Verapamil Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Verapamil Revenue (2021-2032) & (US$ Million) Figure 16. Global Verapamil Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Verapamil Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Verapamil Revenue Market Share by Region (2021-2032) Figure 19. Global Verapamil Sales (2021-2032) & (K Units) Figure 20. Global Verapamil Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Verapamil Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Verapamil Sales YoY (2021-2032) & (K Units) Figure 23. Europe Verapamil Sales YoY (2021-2032) & (K Units) Figure 24. China Verapamil Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Verapamil Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Verapamil Sales YoY (2021-2032) & (K Units) Figure 27. Global Verapamil Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Verapamil Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Verapamil Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Verapamil Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Verapamil Revenue Market Share by Type (2021-2032) Figure 33. Global Verapamil Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Verapamil Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Verapamil Sales Market Share by Type (2021-2032) Figure 36. Global Verapamil Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Verapamil Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Verapamil Revenue Market Share by Application (2021-2032) Figure 39. Global Verapamil Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Verapamil Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Verapamil Sales Market Share by Application (2021-2032) Figure 42. North America Verapamil Revenue Share by Type (2021-2032) Figure 43. North America Verapamil Sales Share by Type (2021-2032) Figure 44. North America Verapamil Revenue Share by Application (2021-2032) Figure 45. North America Verapamil Sales Share by Application (2021-2032) Figure 46. North America Verapamil Revenue Share by Country (2021-2032) Figure 47. North America Verapamil Sales Share by Country (2021-2032) Figure 48. Europe Verapamil Revenue Share by Type (2021-2032) Figure 49. Europe Verapamil Sales Share by Type (2021-2032) Figure 50. Europe Verapamil Revenue Share by Application (2021-2032) Figure 51. Europe Verapamil Sales Share by Application (2021-2032) Figure 52. Europe Verapamil Revenue Share by Country (2021-2032) Figure 53. Europe Verapamil Sales Share by Country (2021-2032) Figure 54. China Verapamil Revenue Share by Type (2021-2032) Figure 55. China Verapamil Sales Share by Type (2021-2032) Figure 56. China Verapamil Revenue Share by Application (2021-2032) Figure 57. China Verapamil Sales Share by Application (2021-2032) Figure 58. Asia Verapamil Revenue Share by Type (2021-2032) Figure 59. Asia Verapamil Sales Share by Type (2021-2032) Figure 60. Asia Verapamil Revenue Share by Application (2021-2032) Figure 61. Asia Verapamil Sales Share by Application (2021-2032) Figure 62. Asia Verapamil Revenue Share by Country (2021-2032) Figure 63. Asia Verapamil Sales Share by Country (2021-2032) Figure 64. SAMEA Verapamil Revenue Share by Type (2021-2032) Figure 65. SAMEA Verapamil Sales Share by Type (2021-2032) Figure 66. SAMEA Verapamil Revenue Share by Application (2021-2032) Figure 67. SAMEA Verapamil Sales Share by Application (2021-2032) Figure 68. SAMEA Verapamil Revenue Share by Country (2021-2032) Figure 69. SAMEA Verapamil Sales Share by Country (2021-2032) Figure 70. Verapamil Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Verapamil Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
  • Injection
  • Others
Applications
  • Hospital Pharmacy
  • Online Sales
  • Retail Pharmacy
  • Others
Companies covered
  • REPLEK FARM
  • YUNGSHIN PHARM IND. CO. LTD
  • The Central Pharmaceutical CO.,Ltd.Tianjin
  • Mylan
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Verapamil Market by Type
  3. 1.2.1 Global Verapamil Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsules
  5. 1.2.3 Tablets
  6. 1.2.4 Injection
  7. 1.2.5 Others
  8. 1.3 Verapamil Market by Application
  9. 1.3.1 Global Verapamil Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Pharmacy
  11. 1.3.3 Online Sales
  12. 1.3.4 Retail Pharmacy
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Verapamil Market Dynamics
  1. 2.1 Verapamil Industry Trends
  2. 2.2 Verapamil Industry Drivers
  3. 2.3 Verapamil Industry Opportunities and Challenges
  4. 2.4 Verapamil Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Verapamil Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Verapamil Revenue by Region
  3. 3.2.1 Global Verapamil Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Verapamil Revenue by Region (2021-2026)
  5. 3.2.3 Global Verapamil Revenue by Region (2027-2032)
  6. 3.2.4 Global Verapamil Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Verapamil Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Verapamil Sales by Region
  9. 3.4.1 Global Verapamil Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Verapamil Sales by Region (2021-2026)
  11. 3.4.3 Global Verapamil Sales by Region (2027-2032)
  12. 3.4.4 Global Verapamil Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Verapamil Revenue by Manufacturers
  2. 4.1.1 Global Verapamil Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Verapamil Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Verapamil Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Verapamil Sales by Manufacturers
  6. 4.2.1 Global Verapamil Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Verapamil Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Verapamil Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Verapamil Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Verapamil Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Verapamil Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Verapamil Manufacturers, Product Type & Application
  13. 4.7 Global Verapamil Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Verapamil Market CR5 and HHI
  16. 4.8.2 2025 Verapamil Tier 1, Tier 2, and Tier 3
5 Verapamil Market by Type
  1. 5.1 Global Verapamil Revenue by Type
  2. 5.1.1 Global Verapamil Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Verapamil Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Verapamil Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Verapamil Sales by Type
  6. 5.2.1 Global Verapamil Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Verapamil Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Verapamil Sales Market Share by Type (2021-2032)
  9. 5.3 Global Verapamil Price by Type
6 Verapamil Market by Application
  1. 6.1 Global Verapamil Revenue by Application
  2. 6.1.1 Global Verapamil Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Verapamil Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Verapamil Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Verapamil Sales by Application
  6. 6.2.1 Global Verapamil Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Verapamil Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Verapamil Sales Market Share by Application (2021-2032)
  9. 6.3 Global Verapamil Price by Application
7 Company Profiles
  1. 7.1 REPLEK FARM
  2. 7.1.1 REPLEK FARM Company Information
  3. 7.1.2 REPLEK FARM Business Overview
  4. 7.1.3 REPLEK FARM Verapamil Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 REPLEK FARM Verapamil Product Portfolio
  6. 7.1.5 REPLEK FARM Recent Developments
  7. 7.2 YUNGSHIN PHARM IND. CO. LTD
  8. 7.2.1 YUNGSHIN PHARM IND. CO. LTD Company Information
  9. 7.2.2 YUNGSHIN PHARM IND. CO. LTD Business Overview
  10. 7.2.3 YUNGSHIN PHARM IND. CO. LTD Verapamil Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 YUNGSHIN PHARM IND. CO. LTD Verapamil Product Portfolio
  12. 7.2.5 YUNGSHIN PHARM IND. CO. LTD Recent Developments
  13. 7.3 The Central Pharmaceutical CO.,Ltd.Tianjin
  14. 7.3.1 The Central Pharmaceutical CO.,Ltd.Tianjin Company Information
  15. 7.3.2 The Central Pharmaceutical CO.,Ltd.Tianjin Business Overview
  16. 7.3.3 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product Portfolio
  18. 7.3.5 The Central Pharmaceutical CO.,Ltd.Tianjin Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Verapamil Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Verapamil Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Abbott Laboratories
  26. 7.5.1 Abbott Laboratories Company Information
  27. 7.5.2 Abbott Laboratories Business Overview
  28. 7.5.3 Abbott Laboratories Verapamil Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Abbott Laboratories Verapamil Product Portfolio
  30. 7.5.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Verapamil Market Size by Type
  2. 8.1.1 North America Verapamil Revenue by Type (2021-2032)
  3. 8.1.2 North America Verapamil Sales by Type (2021-2032)
  4. 8.1.3 North America Verapamil Price by Type (2021-2032)
  5. 8.2 North America Verapamil Market Size by Application
  6. 8.2.1 North America Verapamil Revenue by Application (2021-2032)
  7. 8.2.2 North America Verapamil Sales by Application (2021-2032)
  8. 8.2.3 North America Verapamil Price by Application (2021-2032)
  9. 8.3 North America Verapamil Market Size by Country
  10. 8.3.1 North America Verapamil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Verapamil Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Verapamil Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Verapamil Market Size by Type
  2. 9.1.1 Europe Verapamil Revenue by Type (2021-2032)
  3. 9.1.2 Europe Verapamil Sales by Type (2021-2032)
  4. 9.1.3 Europe Verapamil Price by Type (2021-2032)
  5. 9.2 Europe Verapamil Market Size by Application
  6. 9.2.1 Europe Verapamil Revenue by Application (2021-2032)
  7. 9.2.2 Europe Verapamil Sales by Application (2021-2032)
  8. 9.2.3 Europe Verapamil Price by Application (2021-2032)
  9. 9.3 Europe Verapamil Market Size by Country
  10. 9.3.1 Europe Verapamil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Verapamil Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Verapamil Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Verapamil Market Size by Type
  2. 10.1.1 China Verapamil Revenue by Type (2021-2032)
  3. 10.1.2 China Verapamil Sales by Type (2021-2032)
  4. 10.1.3 China Verapamil Price by Type (2021-2032)
  5. 10.2 China Verapamil Market Size by Application
  6. 10.2.1 China Verapamil Revenue by Application (2021-2032)
  7. 10.2.2 China Verapamil Sales by Application (2021-2032)
  8. 10.2.3 China Verapamil Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Verapamil Market Size by Type
  2. 11.1.1 Asia Verapamil Revenue by Type (2021-2032)
  3. 11.1.2 Asia Verapamil Sales by Type (2021-2032)
  4. 11.1.3 Asia Verapamil Price by Type (2021-2032)
  5. 11.2 Asia Verapamil Market Size by Application
  6. 11.2.1 Asia Verapamil Revenue by Application (2021-2032)
  7. 11.2.2 Asia Verapamil Sales by Application (2021-2032)
  8. 11.2.3 Asia Verapamil Price by Application (2021-2032)
  9. 11.3 Asia Verapamil Market Size by Country
  10. 11.3.1 Asia Verapamil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Verapamil Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Verapamil Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Verapamil Market Size by Type
  2. 12.1.1 SAMEA Verapamil Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Verapamil Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Verapamil Price by Type (2021-2032)
  5. 12.2 SAMEA Verapamil Market Size by Application
  6. 12.2.1 SAMEA Verapamil Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Verapamil Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Verapamil Price by Application (2021-2032)
  9. 12.3 SAMEA Verapamil Market Size by Country
  10. 12.3.1 SAMEA Verapamil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Verapamil Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Verapamil Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Verapamil Value Chain Analysis
  2. 13.1.1 Verapamil Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Verapamil Production Mode & Process
  6. 13.2 Verapamil Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Verapamil Distributors
  9. 13.2.3 Verapamil Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst